Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pre-mRNA-splicing factor CWC25 homolog (CWC25) is a protein that acts as an essential component of the spliceosome, the large ribonucleoprotein complex responsible for removing introns from pre-mRNA in eukaryotic cells. CWC25 is specifically involved in facilitating the first catalytic reaction of splicing after the action of Prp2 and the recruitment of Yju2; it binds to spliceosomal complexes containing splicing intermediates and is required for precise alignment of the 5′ splice site and branch point. CWC25 works in concert with other splicing factors but is not tightly associated with the NTC (nineteen complex), and is released from the spliceosome after the completion of the first reaction. It is classified as a coiled-coil domain-containing protein and is not known to act as a receptor, enzyme, transporter, or established therapeutic target. While CWC25 is conserved across species and necessary for cellular RNA processing, there is currently no evidence of its direct involvement as a biomarker or druggable target in human disease.
Not applicable; CWC25 is not a known therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pre-mRNA-splicing factor CWC25 homolog (CWC25).